- Report
- September 2025
- 150 Pages
China
From €3396EUR$3,850USD£2,983GBP
- Report
- September 2025
- 150 Pages
Canada
From €3396EUR$3,850USD£2,983GBP
- Report
- October 2025
- 105 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,251USD£3,182GBP
The Angiotensin II Receptor market is a segment of the Cardiovascular Drugs market. It is composed of drugs that target the Angiotensin II Receptor, a protein found in the body that plays a role in regulating blood pressure. These drugs are used to treat hypertension, congestive heart failure, and other cardiovascular diseases. They work by blocking the action of Angiotensin II, which helps to reduce blood pressure.
The Angiotensin II Receptor market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. These companies have developed a range of drugs that target the Angiotensin II Receptor, including ACE inhibitors, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors. Show Less Read more